Consumo de licopeno como reductor de incidencia en sujetos con elevado riesgo de padecer cáncer de próstata / Lycopene consumption and reduction of incidence in subjects at high risk of prostate cancer
Medwave
; 13(2)mar. 2013.
Article
in Spanish
| LILACS
| ID: lil-679688
Responsible library:
CL1.1
RESUMEN
Este CAT (Critically Appraised Topics) respondió a la interrogante en sujetos con alto riesgo de padecer cáncer de próstata ¿puede el licopeno reducir la incidencia y mortalidad? Se analizó la pregunta clínica en tres partes paciente, intervención y outcome. El objetivo fue comprobar la validez de los resultados y aplicabilidad respecto de la efectividad del consumo de licopeno en la reducción de la incidencia del cáncer de próstata a partir del articulo Lycopene for the prevention of prostate cáncer de Ilic, et al. (2011).
ABSTRACT
This CAT (Critically Appraised Topic) answered the question in subjects at high risk for prostate cancer, can lycopene reduce incidence and mortality of this cancer? The clinical question was analyzed in three parts patient, intervention and outcome. The purpose was to verify the validity and applicability of the results regarding lycopene consumption on effectiveness in reducing the incidence of prostate cancer.
Full text:
Available
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Prostate Cancer
Database:
LILACS
Main subject:
Prostatic Neoplasms
/
Carotenoids
/
Anticarcinogenic Agents
Type of study:
Etiology study
/
Incidence study
/
Risk factors
/
Screening study
Limits:
Humans
/
Male
Language:
Spanish
Journal:
Medwave
Journal subject:
Medicine
Year:
2013
Document type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Universidad de las Américas/CL